FI48098C - Process for the preparation of 6-halo-4-oxa-3-oxo-androstane derivatives - Google Patents

Process for the preparation of 6-halo-4-oxa-3-oxo-androstane derivatives

Info

Publication number
FI48098C
FI48098C FI683140A FI314068A FI48098C FI 48098 C FI48098 C FI 48098C FI 683140 A FI683140 A FI 683140A FI 314068 A FI314068 A FI 314068A FI 48098 C FI48098 C FI 48098C
Authority
FI
Finland
Prior art keywords
oxa
halo
oxo
preparation
androstane derivatives
Prior art date
Application number
FI683140A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI48098B (en
Inventor
Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of FI48098B publication Critical patent/FI48098B/fi
Publication of FI48098C publication Critical patent/FI48098C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • G—PHYSICS
    • G11—INFORMATION STORAGE
    • G11B—INFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
    • G11B33/00—Constructional parts, details or accessories not provided for in the other groups of this subclass
    • G11B33/02—Cabinets; Cases; Stands; Disposition of apparatus therein or thereon
    • G11B33/04—Cabinets; Cases; Stands; Disposition of apparatus therein or thereon modified to store record carriers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI683140A 1967-11-03 1968-11-04 Process for the preparation of 6-halo-4-oxa-3-oxo-androstane derivatives FI48098C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68030867A 1967-11-03 1967-11-03

Publications (2)

Publication Number Publication Date
FI48098B FI48098B (en) 1974-02-28
FI48098C true FI48098C (en) 1974-06-10

Family

ID=24730576

Family Applications (1)

Application Number Title Priority Date Filing Date
FI683140A FI48098C (en) 1967-11-03 1968-11-04 Process for the preparation of 6-halo-4-oxa-3-oxo-androstane derivatives

Country Status (14)

Country Link
AT (2) AT287932B (en)
BE (1) BE723189A (en)
BR (1) BR6803654D0 (en)
CH (1) CH505855A (en)
DK (1) DK131576C (en)
ES (1) ES359842A1 (en)
FI (1) FI48098C (en)
FR (2) FR1605466A (en)
GB (1) GB1247022A (en)
IE (1) IE33567B1 (en)
IL (1) IL30879A (en)
NL (1) NL6815623A (en)
NO (1) NO132101C (en)
SE (1) SE352360B (en)

Also Published As

Publication number Publication date
IL30879A0 (en) 1968-12-26
ES359842A1 (en) 1970-06-16
DK131576C (en) 1976-01-05
IE33567B1 (en) 1974-08-21
IE33567L (en) 1969-05-03
NO132101B (en) 1975-06-09
BE723189A (en) 1969-04-30
NL6815623A (en) 1969-05-06
DE1805857B2 (en) 1977-06-23
AT287932B (en) 1971-02-10
AT297236B (en) 1972-03-10
CH505855A (en) 1971-04-15
FR1605466A (en) 1976-05-14
SE352360B (en) 1972-12-27
DE1805857A1 (en) 1969-06-26
GB1247022A (en) 1971-09-22
IL30879A (en) 1972-11-28
BR6803654D0 (en) 1973-01-16
FI48098B (en) 1974-02-28
DK131576B (en) 1975-08-04
FR8435M (en) 1971-07-15
NO132101C (en) 1975-09-17

Similar Documents

Publication Publication Date Title
FI48590C (en) Process for the preparation of therapeutically useful azaspiroalkandion compounds.
SE382065B (en) PROCEDURE FOR THE PREPARATION OF LINKOMYCIN DERIVATIVES
FI48727C (en) Process for the preparation of acetylguanidines.
FI48746C (en) Process for the preparation of tetrapolymer latex.
FI49971C (en) Process for the preparation of microbicide-2-nitrofurfurylidenindanone derivatives.
FI50334C (en) Process for the preparation of 1-hydroxy-2-pyridones.
FI50409C (en) Process for the preparation of pyridine-carboxylic acids
FI47575C (en) Analogous process for the preparation of evomonoside derivatives.
FI45551C (en) Process for the preparation of therapeutically useful dehydroepiandro osterone monanthate.
FI50975C (en) Process for the preparation of pyrazinamide derivatives.
FI50407C (en) Process for the preparation of trichloromonosilanes
FI48088C (en) Process for the preparation of 5-phenyl-1H-1,4-benzodiazepine derivatives
FI46727C (en) Process for the preparation of pyridazole derivatives.
FI48090C (en) Process for the preparation of 1-cyanoaminoalkyl-2H-1,4-benzodiazepin-2-one derivatives
FI48724C (en) Process for the preparation of N-carbamoyloxyphenyl carbamates.
FI48190C (en) Process for the preparation of therapeutically active 10alpha-methoxy-9,10-dihydroergoline derivatives
FI48098C (en) Process for the preparation of 6-halo-4-oxa-3-oxo-androstane derivatives
FI51544C (en) Process for the preparation of sweetener mixtures.
SE343302B (en) PROCEDURE FOR THE PREPARATION OF BENSOMORPHENE DERIVATIVES
FI49162C (en) Process for the preparation of therapeutically useful 3-indolyl-aliphatic acid derivatives.
FI49412C (en) Process for the preparation of substituted 3-amino-sydnonimines.
SE333149B (en) PROCEDURE FOR THE PRODUCTION OF BENSIMIDAZOLE-N-OXIDES
FI46722C (en) Process for the preparation of 1alpha-hydroxy-18-methyl-5alpha-H-androstane derivatives.
FI51202C (en) Process for the preparation of 3-thiolated cephalosporin derivatives
FI50879C (en) Process for the preparation of therapeutically active substituted 3-aminoacylamino-thiophenes.